





Recent News
AbbVie tries to escape accountability for overcharging the Dutch healthcare system by 1.2 billion Euros
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had abused...
The Pharmaceutical Accountability Foundation’s case against AbbVie: The Facts
Version 15 November 2023
About Adalimumab/Humira and pricing issues
AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the best...
Answers to written Parliamentary questions by members Ellemeet and Westerveld (both Groenlinks) on the FtV lawsuit against AbbVie
Download the original (Dutch) here:
antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload
Download the English translation here:
Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload